These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33629259)

  • 1. Drug Sensitivity and Drug Repurposing Platform for Cancer Precision Medicine.
    Nweke EE; Thimiri Govinda Raj DB
    Adv Exp Med Biol; 2021; 1326():47-53. PubMed ID: 33629259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro and nanofluidics for high throughput drug screening.
    Mathekga BSP; Nxumalo Z; Thimiri Govinda Raj DB
    Prog Mol Biol Transl Sci; 2022; 187(1):93-120. PubMed ID: 35094783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The University of New Mexico Center for Molecular Discovery.
    Edwards BS; Gouveia K; Oprea TI; Sklar LA
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):256-65. PubMed ID: 24409953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment.
    Kenmogne VL; Nweke EE; Takundwa MM; Fru PN; Thimiri Govinda Raj DB
    Adv Exp Med Biol; 2023; 1410():115-126. PubMed ID: 36289161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel strategies for drug repurposing.
    Takundwa MM; Thimiri Govinda Raj DB
    Prog Mol Biol Transl Sci; 2024; 205():9-21. PubMed ID: 38789188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases.
    Walpole IR; Zaman FY; Zhao P; Marshall VM; Lin FP; Thomas DM; Shackleton M; Antolin AA; Ameratunga M
    Clin Transl Med; 2024 Apr; 14(4):e1657. PubMed ID: 38629623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting Repurposing.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
    Pulley JM; Rhoads JP; Jerome RN; Challa AP; Erreger KB; Joly MM; Lavieri RR; Perry KE; Zaleski NM; Shirey-Rice JK; Aronoff DM
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():333-352. PubMed ID: 31337270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs.
    He B; Xiao Y; Liang H; Huang Q; Du Y; Li Y; Garmire D; Sun D; Garmire LX
    Nat Commun; 2023 Feb; 14(1):993. PubMed ID: 36813801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing for personalized medicine.
    Hora J; Rambhia N; Mani I
    Prog Mol Biol Transl Sci; 2024; 207():107-122. PubMed ID: 38942534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Next generation zebrafish-based drug discovery and precision medicine].
    Tanaka T; Koiwa J
    Nihon Yakurigaku Zasshi; 2019; 154(2):78-83. PubMed ID: 31406047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high throughput biomedicine unit at the institute for molecular medicine Finland: high throughput screening meets precision medicine.
    Pietiainen V; Saarela J; von Schantz C; Turunen L; Ostling P; Wennerberg K
    Comb Chem High Throughput Screen; 2014 May; 17(4):377-86. PubMed ID: 24661208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Throughput and Computational Repurposing for Neglected Diseases.
    Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
    Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
    Pulley JM; Shirey-Rice JK; Lavieri RR; Jerome RN; Zaleski NM; Aronoff DM; Bastarache L; Niu X; Holroyd KJ; Roden DM; Skaar EP; Niswender CM; Marnett LJ; Lindsley CW; Ekstrom LB; Bentley AR; Bernard GR; Hong CC; Denny JC
    Assay Drug Dev Technol; 2017 Apr; 15(3):113-119. PubMed ID: 28379727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Drug Repurposing: Classification of the Research Opportunities and Challenges.
    Sadeghi SS; Keyvanpour MR
    Curr Comput Aided Drug Des; 2020; 16(4):354-364. PubMed ID: 31198115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.